2025–2026 In‑Cycle Grants Award Program
Who can apply: Selected Letter of Intent submissions are invited to submit a full proposal. The Foundation does not accept LOIs or grant applications from pharmaceutical companies, biotechs, or industry for in-cycle grant programs, and such entities may not be collaborators on proposals.
Deadline: July 2026 announcement; Letter of Intent due September 25, 2026; invitation to submit full applications November 27, 2026; grant applications due February 12, 2027; funding decisions in April 2027.
